KUALA LUMPUR: Hwang DBS Vickers Research said in the absence of fresh market stimulating news on Friday, April 1, regional markets may see a slow start in the second quarter of the year.
It said this comes as major equity indices on Wall Street were mixed last night (closing between -0.3% and +0.2%) while crude oil prices jumped 2.3% to US$106.72 per barrel.
HDBSVR said as for Malaysia, following a cumulative gain of 30.9-points or 2.0% over the past three days, the benchmark FBM KLCI could pull back slightly on Friday.
The key market barometer may back off from the immediate resistance threshold of 1,550 while the first support level currently stands at 1,530.
'Still, selective buying interest from investors will probably prevail in two counters that are reportedly involved in possible mergers and acquisition talks.
'According to the local media: (a) Genting Malaysia is said to have won the bid to acquire Tanjong's number forecasts operation for RM2b; and (b) CCM Duopharma Biotech may see the emergence of US-based GlaxoSmithKline as its new controlling shareholder,' it said.
It said this comes as major equity indices on Wall Street were mixed last night (closing between -0.3% and +0.2%) while crude oil prices jumped 2.3% to US$106.72 per barrel.
HDBSVR said as for Malaysia, following a cumulative gain of 30.9-points or 2.0% over the past three days, the benchmark FBM KLCI could pull back slightly on Friday.
The key market barometer may back off from the immediate resistance threshold of 1,550 while the first support level currently stands at 1,530.
'Still, selective buying interest from investors will probably prevail in two counters that are reportedly involved in possible mergers and acquisition talks.
'According to the local media: (a) Genting Malaysia is said to have won the bid to acquire Tanjong's number forecasts operation for RM2b; and (b) CCM Duopharma Biotech may see the emergence of US-based GlaxoSmithKline as its new controlling shareholder,' it said.
No comments:
Post a Comment